{"entity":{"type":"insider","cik":"0001861206","url":"/insider/0001861206","json_url":"/insider/0001861206.json","name":"GV 2021 GP, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":84,"n_filings":32,"first":"2022-05-12","last":"2026-07-29","span_basis":"filed_date"},"name_variants":[{"name":"GV 2021 GP, L.L.C.","source":"filing","n_filings":32,"first_seen":"2022-05-12","last_seen":"2026-07-29"}],"transactions":[{"id":5977592,"accession":"0001168404-26-000041","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000041","line_url":"/filing/0001168404-26-000041#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118138.0,"shares_display":"118,138","price_per_share":18.8996,"price_display":"18.90","price_state":"stated","total_value":2232760.9448,"total_display":"2,232,760.94","total_whole":"2,232,761","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-29","scope":"insider"},{"id":5977583,"accession":"0001168404-26-000041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000041","line_url":"/filing/0001168404-26-000041#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196931.0,"shares_display":"196,931","price_per_share":19.4629,"price_display":"19.46","price_state":"stated","total_value":3832848.3599,"total_display":"3,832,848.36","total_whole":"3,832,848","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-27","filed_date":"2026-07-29","scope":"insider"},{"id":5846513,"accession":"0001168404-26-000039","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000039","line_url":"/filing/0001168404-26-000039#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; Alphabet Inc.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23417.0,"shares_display":"23,417","price_per_share":18.8752,"price_display":"18.88","price_state":"stated","total_value":442000.5584,"total_display":"442,000.56","total_whole":"442,001","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-27","scope":"insider"},{"id":5846509,"accession":"0001168404-26-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000039","line_url":"/filing/0001168404-26-000039#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; Alphabet Inc.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63297.0,"shares_display":"63,297","price_per_share":19.0573,"price_display":"19.06","price_state":"stated","total_value":1206269.9181,"total_display":"1,206,269.92","total_whole":"1,206,270","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-23","filed_date":"2026-07-27","scope":"insider"},{"id":5883433,"accession":"0001168404-26-000036","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000036","line_url":"/filing/0001168404-26-000036#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_display_name":"Alphabet Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49582.0,"shares_display":"49,582","price_per_share":19.2301,"price_display":"19.23","price_state":"stated","total_value":953466.8182,"total_display":"953,466.82","total_whole":"953,467","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-22","filed_date":"2026-07-23","scope":"insider"},{"id":5883429,"accession":"0001168404-26-000036","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001168404-26-000036","line_url":"/filing/0001168404-26-000036","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_display_name":"Alphabet Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22900.0,"shares_display":"22,900","price_per_share":19.055355895196506,"price_display":"19.06","price_state":"stated","total_value":436367.65,"total_display":"436,367.65","total_whole":"436,368","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider","n_lines":2},{"id":5957642,"accession":"0001168404-26-000031","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001168404-26-000031","line_url":"/filing/0001168404-26-000031#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.; Alphabet Inc.","owner_display_name":"GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18386.0,"shares_display":"18,386","price_per_share":18.8654,"price_display":"18.87","price_state":"stated","total_value":346859.2444,"total_display":"346,859.24","total_whole":"346,859","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-20","filed_date":"2026-07-21","scope":"insider"},{"id":5957637,"accession":"0001168404-26-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000031","line_url":"/filing/0001168404-26-000031#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; GV 2019 GP, L.P.; Alphabet Inc.","owner_display_name":"GV 2021 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20534.0,"shares_display":"20,534","price_per_share":18.6819,"price_display":"18.68","price_state":"stated","total_value":383614.1346,"total_display":"383,614.13","total_whole":"383,614","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-17","filed_date":"2026-07-21","scope":"insider"},{"id":6169980,"accession":"0001168404-26-000029","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000029","line_url":"/filing/0001168404-26-000029#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2019, L.P.","owner_display_name":"Alphabet Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19595.0,"shares_display":"19,595","price_per_share":18.7297,"price_display":"18.73","price_state":"stated","total_value":367008.4715,"total_display":"367,008.47","total_whole":"367,008","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-17","scope":"insider"},{"id":6169967,"accession":"0001168404-26-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001168404-26-000029","line_url":"/filing/0001168404-26-000029","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2019, L.P.","owner_display_name":"Alphabet Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74492.0,"shares_display":"74,492","price_per_share":19.66231272082908,"price_display":"19.66","price_state":"stated","total_value":1464684.9992,"total_display":"1,464,685.00","total_whole":"1,464,685","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider","n_lines":2},{"id":5781843,"accession":"0001168404-26-000025","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000025","line_url":"/filing/0001168404-26-000025","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.; GV 2019, L.P.","owner_display_name":"Alphabet Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87475.0,"shares_display":"87,475","price_per_share":23.749403195198628,"price_display":"23.75","price_state":"stated","total_value":2077479.0445,"total_display":"2,077,479.04","total_whole":"2,077,479","shares_owned_after":42065.0,"shares_owned_after_display":"42,065","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider","n_lines":2},{"id":5781840,"accession":"0001168404-26-000025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001168404-26-000025","line_url":"/filing/0001168404-26-000025#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"Alphabet Inc.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.; GV 2019, L.P.","owner_display_name":"Alphabet Inc.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60077.0,"shares_display":"60,077","price_per_share":23.0093,"price_display":"23.01","price_state":"stated","total_value":1382329.7161,"total_display":"1,382,329.72","total_whole":"1,382,330","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-18","scope":"insider"},{"id":5821726,"accession":"0001168404-26-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001168404-26-000007","line_url":"/filing/0001168404-26-000007","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Ethos Technologies Inc.","issuer_ticker":"LIFE","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; Alphabet Inc.; GV 2017 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2017, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; GV 2019, L.P.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1845308.0,"shares_display":"1,845,308","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":35060852.0,"total_display":"35,060,852.00","total_whole":"35,060,852","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-01-30","scope":"insider","n_lines":2},{"id":5155131,"accession":"0001415889-25-021025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021025","line_url":"/filing/0001415889-25-021025#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; Alphabet Inc.; GV 2021, L.P.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500000.0,"shares_display":"1,500,000","price_per_share":3.3,"price_display":"3.30","price_state":"stated","total_value":4950000.0,"total_display":"4,950,000.00","total_whole":"4,950,000","shares_owned_after":3262440.0,"shares_owned_after_display":"3,262,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":7922601,"accession":"0001209191-23-039122","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-039122","line_url":"/filing/0001209191-23-039122#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.","owner_display_name":"GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19003.0,"shares_display":"19,003","price_per_share":14.9711,"price_display":"14.97","price_state":"stated","total_value":284495.8133,"total_display":"284,495.81","total_whole":"284,496","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-22","scope":"insider"},{"id":7922595,"accession":"0001209191-23-039122","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-039122","line_url":"/filing/0001209191-23-039122#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.","owner_display_name":"GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37405.0,"shares_display":"37,405","price_per_share":15.0581,"price_display":"15.06","price_state":"stated","total_value":563248.2305,"total_display":"563,248.23","total_whole":"563,248","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":7972549,"accession":"0001209191-23-038363","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-038363","line_url":"/filing/0001209191-23-038363#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; Alphabet Inc.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6532.0,"shares_display":"6,532","price_per_share":15.0198,"price_display":"15.02","price_state":"stated","total_value":98109.3336,"total_display":"98,109.33","total_whole":"98,109","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-20","scope":"insider"},{"id":7972543,"accession":"0001209191-23-038363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-038363","line_url":"/filing/0001209191-23-038363#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2021, L.P.; Alphabet Inc.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66659.0,"shares_display":"66,659","price_per_share":14.9166,"price_display":"14.92","price_state":"stated","total_value":994325.6394,"total_display":"994,325.64","total_whole":"994,326","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-20","scope":"insider"},{"id":7922480,"accession":"0001209191-23-037334","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-037334","line_url":"/filing/0001209191-23-037334#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28960.0,"shares_display":"28,960","price_per_share":14.8717,"price_display":"14.87","price_state":"stated","total_value":430684.432,"total_display":"430,684.43","total_whole":"430,684","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":7922473,"accession":"0001209191-23-037334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037334","line_url":"/filing/0001209191-23-037334#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28100.0,"shares_display":"28,100","price_per_share":15.1282,"price_display":"15.13","price_state":"stated","total_value":425102.42,"total_display":"425,102.42","total_whole":"425,102","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider"},{"id":8723932,"accession":"0001209191-23-036666","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-036666","line_url":"/filing/0001209191-23-036666#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16031.0,"shares_display":"16,031","price_per_share":14.9804,"price_display":"14.98","price_state":"stated","total_value":240150.7924,"total_display":"240,150.79","total_whole":"240,151","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-13","scope":"insider"},{"id":8723928,"accession":"0001209191-23-036666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-036666","line_url":"/filing/0001209191-23-036666#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15672.0,"shares_display":"15,672","price_per_share":14.4834,"price_display":"14.48","price_state":"stated","total_value":226983.8448,"total_display":"226,983.84","total_whole":"226,984","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-13","scope":"insider"},{"id":8723910,"accession":"0001209191-23-035849","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-035849","line_url":"/filing/0001209191-23-035849#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.7373,"price_display":"15.74","price_state":"stated","total_value":78686.5,"total_display":"78,686.50","total_whole":"78,687","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-09","scope":"insider"},{"id":8723906,"accession":"0001209191-23-035849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035849","line_url":"/filing/0001209191-23-035849#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; Alphabet Inc.; GV 2021 GP, L.P.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":16.9247,"price_display":"16.92","price_state":"stated","total_value":253870.5,"total_display":"253,870.50","total_whole":"253,871","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-07","filed_date":"2023-06-09","scope":"insider"},{"id":8403930,"accession":"0001209191-23-035068","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-035068","line_url":"/filing/0001209191-23-035068#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29975.0,"shares_display":"29,975","price_per_share":17.0197,"price_display":"17.02","price_state":"stated","total_value":510165.5075,"total_display":"510,165.51","total_whole":"510,166","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-06","filed_date":"2023-06-07","scope":"insider"},{"id":8403924,"accession":"0001209191-23-035068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-035068","line_url":"/filing/0001209191-23-035068#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22434.0,"shares_display":"22,434","price_per_share":16.6984,"price_display":"16.70","price_state":"stated","total_value":374611.9056,"total_display":"374,611.91","total_whole":"374,612","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-05","filed_date":"2023-06-07","scope":"insider"},{"id":8042906,"accession":"0001209191-23-033697","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-033697","line_url":"/filing/0001209191-23-033697","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45223.0,"shares_display":"45,223","price_per_share":14.355388934834044,"price_display":"14.36","price_state":"stated","total_value":649193.7538,"total_display":"649,193.75","total_whole":"649,194","shares_owned_after":471.0,"shares_owned_after_display":"471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider","n_lines":2},{"id":8042897,"accession":"0001209191-23-033697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033697","line_url":"/filing/0001209191-23-033697#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019 GP, L.P.; Alphabet Inc.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.L.C.; GV 2019, L.P.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16633.0,"shares_display":"16,633","price_per_share":13.6478,"price_display":"13.65","price_state":"stated","total_value":227003.8574,"total_display":"227,003.86","total_whole":"227,004","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-31","filed_date":"2023-06-02","scope":"insider"},{"id":8545335,"accession":"0001209191-23-033107","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-033107","line_url":"/filing/0001209191-23-033107#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019, L.P.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; Alphabet Inc.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16805.0,"shares_display":"16,805","price_per_share":13.7007,"price_display":"13.70","price_state":"stated","total_value":230240.2635,"total_display":"230,240.26","total_whole":"230,240","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-05-31","scope":"insider"},{"id":8545329,"accession":"0001209191-23-033107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-033107","line_url":"/filing/0001209191-23-033107#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021 GP, L.P.; GV 2019, L.P.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.; GV 2019 GP, L.L.C.; Alphabet Inc.","owner_display_name":"GV 2021 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12602.0,"shares_display":"12,602","price_per_share":13.6965,"price_display":"13.70","price_state":"stated","total_value":172603.293,"total_display":"172,603.29","total_whole":"172,603","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-26","filed_date":"2023-05-31","scope":"insider"},{"id":8438864,"accession":"0001209191-23-032529","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-032529","line_url":"/filing/0001209191-23-032529#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23161.0,"shares_display":"23,161","price_per_share":13.3834,"price_display":"13.38","price_state":"stated","total_value":309972.9274,"total_display":"309,972.93","total_whole":"309,973","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-25","filed_date":"2023-05-26","scope":"insider"},{"id":8438857,"accession":"0001209191-23-032529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-032529","line_url":"/filing/0001209191-23-032529#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2021, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7900.0,"shares_display":"7,900","price_per_share":13.6608,"price_display":"13.66","price_state":"stated","total_value":107920.32,"total_display":"107,920.32","total_whole":"107,920","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-26","scope":"insider"},{"id":8679731,"accession":"0001209191-23-031916","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-031916","line_url":"/filing/0001209191-23-031916#line-4","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2021 GP, L.P.","owner_display_name":"GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43939.0,"shares_display":"43,939","price_per_share":14.7397,"price_display":"14.74","price_state":"stated","total_value":647647.6783,"total_display":"647,647.68","total_whole":"647,648","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-23","filed_date":"2023-05-24","scope":"insider"},{"id":8679727,"accession":"0001209191-23-031916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-031916","line_url":"/filing/0001209191-23-031916#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2021 GP, L.P.","owner_display_name":"GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87922.0,"shares_display":"87,922","price_per_share":14.1272,"price_display":"14.13","price_state":"stated","total_value":1242091.6784,"total_display":"1,242,091.68","total_whole":"1,242,092","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-22","filed_date":"2023-05-24","scope":"insider"},{"id":8703157,"accession":"0001209191-23-031450","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-23-031450","line_url":"/filing/0001209191-23-031450#line-5","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_display_name":"GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63212.0,"shares_display":"63,212","price_per_share":13.875,"price_display":"13.88","price_state":"stated","total_value":877066.5,"total_display":"877,066.50","total_whole":"877,067","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-19","filed_date":"2023-05-22","scope":"insider"},{"id":8703150,"accession":"0001209191-23-031450","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-031450","line_url":"/filing/0001209191-23-031450","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.L.C.; Alphabet Inc.; GV 2019, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.","owner_display_name":"GV 2019 GP, L.L.C.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27098.0,"shares_display":"27,098","price_per_share":13.036801306369474,"price_display":"13.04","price_state":"stated","total_value":353271.2418,"total_display":"353,271.24","total_whole":"353,271","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-18","filed_date":"2023-05-22","scope":"insider","n_lines":2},{"id":8652586,"accession":"0001209191-23-030621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-030621","line_url":"/filing/0001209191-23-030621#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":12.7733,"price_display":"12.77","price_state":"stated","total_value":191599.5,"total_display":"191,599.50","total_whole":"191,600","shares_owned_after":10735324.0,"shares_owned_after_display":"10,735,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":8652583,"accession":"0001209191-23-030621","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-030621","line_url":"/filing/0001209191-23-030621#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50649.0,"shares_display":"50,649","price_per_share":12.5901,"price_display":"12.59","price_state":"stated","total_value":637675.9749,"total_display":"637,675.97","total_whole":"637,676","shares_owned_after":10750324.0,"shares_owned_after_display":"10,750,324","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":7835256,"accession":"0001209191-23-029789","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-029789","line_url":"/filing/0001209191-23-029789#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":157952.0,"shares_display":"157,952","price_per_share":12.7386,"price_display":"12.74","price_state":"stated","total_value":2012087.3472,"total_display":"2,012,087.35","total_whole":"2,012,087","shares_owned_after":10800973.0,"shares_owned_after_display":"10,800,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-16","scope":"insider"},{"id":7835253,"accession":"0001209191-23-029789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029789","line_url":"/filing/0001209191-23-029789#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019 GP, L.P.; GV 2021 GP, L.L.C.; GV 2019, L.P.; GV 2021, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; Alphabet Inc.","owner_display_name":"GV 2019 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27290.0,"shares_display":"27,290","price_per_share":12.7234,"price_display":"12.72","price_state":"stated","total_value":347221.586,"total_display":"347,221.59","total_whole":"347,222","shares_owned_after":10958925.0,"shares_owned_after_display":"10,958,925","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-12","filed_date":"2023-05-16","scope":"insider"},{"id":8679525,"accession":"0001209191-23-029033","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-029033","line_url":"/filing/0001209191-23-029033","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26626.0,"shares_display":"26,626","price_per_share":13.127518988958162,"price_display":"13.13","price_state":"stated","total_value":349533.3206,"total_display":"349,533.32","total_whole":"349,533","shares_owned_after":10991022.0,"shares_owned_after_display":"10,991,022","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-12","scope":"insider","n_lines":2},{"id":8679522,"accession":"0001209191-23-029033","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-029033","line_url":"/filing/0001209191-23-029033#line-1","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2021, L.P.; GV 2019, L.P.; Alphabet Inc.; GV 2019 GP, L.P.; GV 2019 GP, L.L.C.; GV 2021 GP, L.P.; GV 2021 GP, L.L.C.","owner_display_name":"GV 2021, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87397.0,"shares_display":"87,397","price_per_share":14.0257,"price_display":"14.03","price_state":"stated","total_value":1225804.1029,"total_display":"1,225,804.10","total_whole":"1,225,804","shares_owned_after":11012841.0,"shares_owned_after_display":"11,012,841","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-10","filed_date":"2023-05-12","scope":"insider"},{"id":8679493,"accession":"0001209191-23-028464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-028464","line_url":"/filing/0001209191-23-028464#line-2","is_derivative":false,"issuer_cik":"0001652044","issuer_name":"Prime Medicine, Inc.","issuer_ticker":"PRME","issuer_name_source":null,"issuer_url":"/issuer/0001652044","owner_cik":null,"owner_name":"GV 2019, L.P.; GV 2021 GP, L.L.C.; GV 2021, L.P.; GV 2019 GP, L.P.; GV 2021 GP, L.P.; GV 2019 GP, L.L.C.; Alphabet Inc.","owner_display_name":"GV 2019, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":321238.0,"shares_display":"321,238","price_per_share":14.0787,"price_display":"14.08","price_state":"stated","total_value":4522613.4306,"total_display":"4,522,613.43","total_whole":"4,522,613","shares_owned_after":11100238.0,"shares_owned_after_display":"11,100,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-10","scope":"insider"}],"collapsed":true,"next_cursor":"2023-05-09|8679493","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001788451","name":"Ethos Technologies Inc.","url":"/issuer/0001788451","role":"Ten percent owner","n_filings":7,"first_seen":"2026-01-30","last_seen":"2026-07-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001894562","name":"Prime Medicine, Inc.","url":"/issuer/0001894562","role":"Ten percent owner, Other","n_filings":17,"first_seen":"2022-10-26","last_seen":"2025-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001653482","name":"Gitlab Inc.","url":"/issuer/0001653482","role":"Other","n_filings":8,"first_seen":"2022-05-12","last_seen":"2023-05-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861206","retrieved_at":"2026-08-22T21:10:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}